Key facts
- This page summarizes Stuart Woolf's Form 4 filing for MARRONE BIO INNOVATIONS INC.
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Jan 2022, 15:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
Footnote F2
The restricted stock units vest with respect to 100% of the total shares subject to the grant on December 31, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.